
Teen Mt. Whitney hiker who walked off 120-foot cliff in delirium makes slow recovery, family says
Early this month, Zane Wach, 14, ascended Mt. Whitney in the Sierra Nevada with his father, Ryan, an experienced hiker, on the Mountaineer's Route — an eight-mile route described as 'steep' and 'unmaintained' by the Sierra Mountain Center. As the Wachs began their descent toward their car on a safer route, Zane began to experience hallucinations of 'snowmen,' on the trail and was in an 'altered mental state,' Ryan Wach told SFGate.
'It was completely bizarre,' Wach said in an interview with SFGate. 'He told me he couldn't tell if he was dreaming or not, and he would shake his head in disbelief, like, 'This is not real.' Like he was in the movie 'Inception' or something.'
Mt. Whitney's peaks draw 30,000 hikers each year and an average of two suffer fatal injuries annually, according to the U.S. Forest Service. Climbers who wish to ascend during peak spring and summer months, between May 1 and Nov. 1, must apply for a permit through a lottery system, which limits the mountain to 100 climbers per day and only 60 for 'difficult' overnight climbs.
The Mountaineer's Route is a path for experienced hikers to ascend to the summit of Mt. Whitney, which is over 14,000 feet in elevation. It is unclear whether the Wachs reached the summit, but according to the CDC, any travelers reaching altitudes of 8,000 feet — sometimes lower — are susceptible to altitude sickness and symptoms, such as confusion and feelings of 'intoxication,' that are usually associated with brain swelling.
Zane phased in and out of delirium as they continued their descent, and the two stopped periodically to take a rest while Zane attempted to regain lucidity, Wach told the Independent. His son would 'sleepwalk' away from his father toward the edges of the trail, Wach added.
Another group of hikers, including an EMT, evaluated Zane's condition once they noticed his mental deterioration. Wach told the Independent that once he briefly took his eyes off of his son, Zane 'veered' toward the edge of a deep slope and fell an estimated 120 feet.
'I didn't see how there would be a way for him to survive it, so I screamed. I was yelling 'no,'' Wach told the Independent.
However, Zane was semi-conscious when his father reached him, and the nearby hikers contacted rescue teams, Wach said. The Inyo County Search and Rescue team worked for around six hours to rescue Zane as his father attempted to keep him warm, authorities said.
Zane was flown to the Sunrise Children's Hospital in Las Vegas, the nearest pediatric trauma center, according to the family's GoFundMe. While Zane had suffered head trauma and was put into a medically-induced coma, he was spared any major bodily injury. Wach told SFGATE that his son fractured an ankle and a finger and broke a part of his pelvis.
Zane remains in a medically-induced coma, but began to breathe without medical assistance nearly three weeks after his fall in a 'giant milestone' toward his recovery, Wach said in a post on Facebook shared by Zane's grandmother.
Wach added that doctors are currently attempting to wean Zane off heavy medication.
'He's been on a lot of heavy drugs for a while and getting off those is extremely hard and painful,' Wach wrote. 'As parents, it's terrible to watch. We hope he gets through this with the least possible suffering,'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fox News
an hour ago
- Fox News
How sensationalized headlines about 'brain plastic' are undermining trust in safe, sustainable materials
Earlier this year, a terrifying claim swept headlines and social media: "You have a spoon's worth of plastic in your brain." The warning, based on a study published in Nature Medicine, set off a cultural firestorm, dominating news cycles, TikToks and dinner table conversations. It was the kind of phrase designed to go viral, and it did. But here's what didn't go viral: the follow-up. Experts later flagged the study for a critical flaw: To quantify microplastics in samples, the study relied on equipment with limitations in distinguishing plastics from other materials, leading to potential false positives. An independent expert noted: "The method is lauded for its ability to detect smaller micro- and nanoplastics than other methods can, but it will give you a lot of false positives if you do not adequately remove biological material from the sample. Most of the presumed plastic they found is polyethylene, which to me really indicates that they didn't really clean up their samples properly." The nuance, though important, didn't make the headlines. This highlights a broader issue: there's no globally standardized methods for the collection, detection and quantification of microplastics. Some microplastics studies may fail to identify whether the particle is a mineral, an organic material or something else, yet still misidentify them and claim they are microplastics. And without standardized methodologies for identifying and quantifying the different types of particles, it is difficult to generate reliable data and assess their true impact. The U.S. Food and Drug Administration (FDA) states, "While there are many studies on microplastics in food, the current state of science is limited in its ability to inform regulatory risk assessment… due to several factors, including a continued lack of standardized definitions, reference materials, sample collection and preparation procedures, and appropriate quality controls, to name a few." Yet recent coverage has prioritized drama over scientific nuance, creating confusion rather than clarity. Let's be clear: microplastics are real. Everyday life, from tire dust to synthetic fibers, produces these particles. They're in the environment and potentially our bodies. But presence alone doesn't constitute a crisis. The real question is what this means for human health and how to respond responsibly. The FDA has made clear that "current scientific evidence does not demonstrate that levels of microplastics or nanoplastics detected in foods pose a risk to human health." When we treat preliminary research as settled science – or worse, viral clickbait – we lose the ability to make smart decisions. This is particularly true in the case of materials like PET, the plastic used in food packaging, water bottles and medical supplies. PET is among the safest, most rigorously tested plastics, approved globally by regulators including the FDA and EFSA. Why is this misinformation dangerous? Because it undermines trust in safe and sustainable materials like PET, which is both lightweight and recyclable. According to life cycle assessments (LCA), a PET bottle produces significantly lower greenhouse gas (GHG) emissions than alternative containers like glass bottles or aluminum cans, and requires less energy to produce. It enables safe hydration, reduces food waste and makes modern healthcare possible. Yet consumers increasingly question PET, not because science changed, but because headlines did. That disconnect carries real-world consequences. This is exactly why it is so important for our regulatory agencies to step up and address the lack of standardization in microplastics research and to develop methods and standards that allow for consistent and comparable results in research. Only then will we be able to have a more disciplined public conversation around microplastics that we can be confident is based on dependable evidence, and which stops the confusion of comparing apples to oranges. None of this is to dismiss the broader challenge of plastic pollution. Our industry – and society – must invest in better systems: smarter product design, stronger recycling infrastructure and more rigorous scientific research. But meaningful progress starts with clarity, not confusion. The public deserves facts. Not just headlines.

NBC Sports
2 hours ago
- NBC Sports
Former NFL LB Bryan Braman fights rare form of brain cancer
Former NFL linebacker Bryan Braman is fighting a rare and aggressive form of brain cancer, at the age of 38. Diagnosed in February, he has had multiple surgeries while undergoing treatment in Seattle. Via a GoFundMe page has been created to assist Braman with expenses arising from his treatment. As of this posted, more than $53,000 has been raised. Former teammate J.J. Watt has given $10,000, and other former teammates have contributed. Braman and Watt joined the Texans in the year — 2011. Braman was undrafted, but he made the team and remained in Houston for three seasons. He played the next four years with the Eagles. Braman capped his NFL career with a win over the Patriots in Super Bowl LII. En route to the championship, Braman blocked a punt in the divisional round win over the Falcons. Braman, who appeared in 97 career regular-season games, contributed mainly on special teams. One of his more memorable moments came in the final game of his rookie season, when he lost his helmet and still made the tackle on a punt return.


New York Post
a day ago
- New York Post
Former NFL linebacker Bryan Braman battling ‘very rare' cancer
Bryan Braman, who spent seven years in the NFL and won a Super Bowl with the Eagles in February 2018, has been battling a 'life threatening' and 'very rare' cancer, according to a GoFundMe page. While the fundraiser didn't list the specific cancer, Braman, 38, underwent CAR T-cell therapy in Seattle as part of a 12-week treatment program and needed to sell his final car — while also not owning a home — to pay for a motel to stay in and for the treatment. William Jones, the organizer, created the page in February and shared an update on June 20 that said Braman was back with family, but has encountered obstacles recovering from multiple surgeries as a result of his 'lowered immunity due to all of these treatments.' Advertisement 4 Bryan Braman is pictured during the Eagles' preseason game against the Steelers in August 2016. Getty Images 4 Bryan Braman signed with the Texans as an undrafted free agent to start his NFL career. Getty Images 'By the time he was able to recover so he could continue with the chemo, the cancer has grown expedentially [sic] faster, and is is [sic] now growing around his vital organs,' Jones wrote. 'The Dr's are now concerned because of his treatment, his chemo options are very limited. They have tried all of the various treatment options, and unfortunately, none of them are working against this cancer. 'But Bryan has not given up. He is looking into other trial treatment programs, and is determined to never give up.' Advertisement The page — with a fundraising goal of $25,000 — had raised over $38,000 as of Friday morning, including a $10,000 donation from former Texans teammate J.J. Watt. 'Bryan will be able to get the necessities for his diet,' Jones wrote in the June 20 update. 'He needs to keep up his energy through his diet, and his foods/vitamins are extremely expensive, as are fresh juices which are what he needs. These donations will also go along [sic] way too [sic] help cover some of the treatment costs that are not covered by insurances. That has greatly helped Bryan to not have to focus on those, and now he can relaxe [sic] and recuperate.' Braman, a linebacker and Spokane, Wash. native, signed with the Texans in 2011 as an undrafted free agent out of West Texas A&M and spent the first three years of his career in Houston, mostly carving out a special teams role. Advertisement 4 Bryan Braman sacks Jets quarterback Matt Flynn during a September 2015 game. Getty Images 4 Bryan Braman walks off the field after the Eagles' October 2014 game against the Cardinals. Getty Images He then played with the Eagles from 2014-16 and became one of their core special teams players. Braman returned to Philadelphia just before the start of the 2017 postseason after the Saints cut him — on injured reserve at the time with an undisclosed injury — at the end of the preseason. Advertisement He recorded one tackle on a kickoff during the Eagles' Super Bowl win over the Patriots that year, which marked his final NFL season.